HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Erik A Imel Selected Research

Autosomal Dominant Hypophosphatemic Rickets

1/2020Oral Iron Replacement Normalizes Fibroblast Growth Factor 23 in Iron-Deficient Patients With Autosomal Dominant Hypophosphatemic Rickets.
3/2014Iron and fibroblast growth factor 23 in X-linked hypophosphatemia.
11/2011Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans.
4/2007FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Erik A Imel Research Topics

Disease

21Hypophosphatemia
01/2022 - 06/2006
21Familial Hypophosphatemic Rickets (X-Linked Hypophosphatemia)
01/2022 - 08/2007
16Rickets (Rachitis)
01/2022 - 10/2006
8Congenital Abnormalities (Deformity)
01/2022 - 08/2007
8Osteomalacia
10/2019 - 06/2006
5Pain (Aches)
01/2021 - 01/2018
4Nephrocalcinosis
01/2021 - 04/2014
4Autosomal Dominant Hypophosphatemic Rickets
01/2020 - 04/2007
4Hypercalcemia (Milk Alkali Syndrome)
10/2019 - 09/2007
4Hyperphosphatemia
04/2015 - 11/2006
4Calcinosis
04/2010 - 11/2006
3Osteoporosis
01/2022 - 02/2016
3Neoplasms (Cancer)
07/2020 - 06/2006
3Hyperparathyroidism
10/2019 - 01/2015
3Hypercalciuria
09/2019 - 10/2006
2Osteopetrosis
06/2022 - 01/2019
2Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal)
01/2022 - 10/2021
2Congenital adrenal hyperplasia due to 21 hydroxylase deficiency
01/2022 - 10/2021
2Fatigue
01/2021 - 01/2021
2Bone Diseases (Bone Disease)
10/2020 - 01/2015
2Inborn Genetic Diseases (Disease, Hereditary)
09/2019 - 06/2013
2Familial Hypophosphatemia (Phosphate Diabetes)
08/2019 - 04/2007
2Osteoarthritis
01/2018 - 12/2016
2Metabolic Bone Diseases (Osteopenia)
04/2016 - 01/2015
2Hyperostosis-hyperphosphatemia syndrome
04/2010 - 05/2007
2Oncogenic osteomalacia
12/2009 - 06/2006
2Paraneoplastic Syndromes (Paraneoplastic Syndrome)
12/2009 - 06/2006
1Hypophosphatasia
01/2022
1Chronic Disease (Chronic Diseases)
01/2022
1COVID-19
01/2022
1Musculoskeletal Diseases (Musculoskeletal Disease)
01/2022
1Periprosthetic Fractures
01/2022
1Abscess
01/2022
1Stomatognathic Diseases (Dental Disease)
01/2021
1Enthesopathy
01/2021
1Hypophosphatemic Bone Disease
10/2020
1Chronic Renal Insufficiency
07/2020
1Liver Diseases (Liver Disease)
07/2020
1Hypertension (High Blood Pressure)
07/2020
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
07/2020
1Headache (Headaches)
01/2020
1Nausea
01/2020
1Iron-Deficiency Anemia (Anemia, Iron Deficiency)
01/2020
1Drug-Related Side Effects and Adverse Reactions
01/2020
1Secondary Hyperparathyroidism
10/2019
1Bone Resorption
01/2019
1Body Weight (Weight, Body)
01/2018
1Hypocalcemia
01/2017
1Arthralgia (Joint Pain)
12/2016
1Iron Deficiencies
05/2016

Drug/Important Bio-Agent (IBA)

28Phosphates (Orthophosphate)IBA
01/2022 - 06/2006
18Fibroblast Growth Factor-23IBA
01/2022 - 06/2006
16burosumabIBA
01/2022 - 04/2014
8Vitamin DFDA LinkGeneric
01/2022 - 10/2008
7Calcitriol (Calcijex)FDA LinkGeneric
01/2022 - 04/2007
7Phosphorus (Red Phosphorus)IBA
01/2021 - 07/2015
6Monoclonal AntibodiesIBA
01/2022 - 01/2018
6IronIBA
01/2020 - 11/2011
61,25-dihydroxyvitamin DIBA
04/2016 - 10/2006
4Parathyroid Hormone (Parathormone)IBA
01/2020 - 09/2007
3Thymidine Monophosphate (TMP)IBA
02/2016 - 11/2006
2SaltsIBA
01/2022 - 09/2019
2Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
01/2020 - 03/2012
2MineralsIBA
01/2020 - 09/2007
2alfacalcidolIBA
09/2019 - 08/2019
2CreatinineIBA
01/2019 - 04/2014
2Proteins (Proteins, Gene)FDA Link
03/2016 - 06/2006
2GalactosamineIBA
09/2007 - 05/2007
2Uridine Diphosphate (UDP)IBA
09/2007 - 05/2007
2Polypeptide N-acetylgalactosaminyltransferaseIBA
09/2007 - 05/2007
1Therapeutic UsesIBA
06/2022
1crinecerfontIBA
01/2022
1Alkaline PhosphataseIBA
01/2022
1AndrogensIBA
01/2022
1Hormones (Hormone)IBA
01/2022
1Hydrocortisone (Cortisol)FDA LinkGeneric
01/2022
1GlucocorticoidsIBA
10/2021
1Prealbumin (Transthyretin)IBA
07/2020
1AlbuminsIBA
07/2020
1Ferritins (Ferritin)IBA
01/2020
1Hemoglobins (Hemoglobin)IBA
01/2020
1iron isomaltoside 1000IBA
01/2020
1ferric carboxymaltoseIBA
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1ferric derisomaltoseIBA
01/2020
1ThiazidesIBA
09/2019
1eldecalcitol (ED 71)IBA
08/2019
1paricalcitol (Zemplar)FDA Link
08/2019
1Neutralizing AntibodiesIBA
08/2019
1PHEX Phosphate Regulating Neutral EndopeptidaseIBA
01/2019
1interferon gamma-1bFDA Link
01/2019
1CalciumIBA
01/2018
1Amino AcidsFDA Link
01/2017
1dimemorfan (AT 17)IBA
01/2017
1Transferrin (beta 2 Transferrin)IBA
03/2016

Therapy/Procedure

12Therapeutics
01/2022 - 11/2011
1Hematopoietic Stem Cell Transplantation
06/2022
1Patient Transfer (Patient Dumping)
01/2022
1Parathyroidectomy
10/2019
1Aftercare (After-Treatment)
12/2016